Business Description
RenovoRx is a drug development company focused on improving treatment results for cancer patients through targeted combination therapies. Its primary candidate delivers the chemotherapy drug gemcitabine directly via a specialized catheter system called RenovoCath, currently in Phase III trials for locally advanced pancreatic cancer. Founded in 2009, the company is based in Mountain View, California.